The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Antibiotic Adjuvants: Rescuing Antibiotics from Resistance
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Self-citationDrugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
Antibacterial drug discovery in the resistance era
Brown, E. D., & Wright, G. D. (2016) · Nature · doi:10.1038/nature17042 · Cited by 2,247
Self-citationThe Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.105-116.2001 · Cited by 903
Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerus
Reading, C., & Cole, M. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.11.5.852 · Cited by 739
Combination approaches to combat multidrug-resistant bacteria
Worthington, R. J., & Melander, C. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.12.006 · Cited by 625
ESKAPEing the labyrinth of antibacterial discovery
Tommasi, R., Brown, D. G., Walkup, G. K., Manchester, J. I., & Miller, A. A. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4572 · Cited by 608
Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It
Zgurskaya, H. I., López, C. A., & Gnanakaran, S. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00097 · Cited by 580
Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance
King, A. M., Reid-Yu, S. A., Wang, W., King, D. T., De Pascale, G., Strynadka, N. C., Walsh, T. R., Coombes, B. K., & Wright, G. D. (2014) · Nature · doi:10.1038/nature13445 · Cited by 554
Self-citationModulating immunity as a therapy for bacterial infections
Hancock, R. E. W., Nijnik, A., & Philpott, D. J. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2745 · Cited by 535
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
Ejim, L., Farha, M. A., Falconer, S. B., Wildenhain, J., Coombes, B. K., Tyers, M., Brown, E. D., & Wright, G. D. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.559 · Cited by 525
Self-citationWorldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative Bacteria
Dortet, L., Poirel, L., & Nordmann, P. (2014) · BioMed Research International · doi:10.1155/2014/249856 · Cited by 501
Aminoglycoside Antibiotics in the 21st Century
Becker, B., & Cooper, M. A. (2013) · ACS Chemical Biology · doi:10.1021/cb3005116 · Cited by 419
Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
Brown, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4675 · Cited by 359
Antibiotic Adjuvants: Diverse Strategies for Controlling Drug‐Resistant Pathogens
Gill, E. E., Franco, O. L., & Hancock, R. E. W. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12478 · Cited by 319
A Broad-Spectrum Antibiofilm Peptide Enhances Antibiotic Action against Bacterial Biofilms
Reffuveille, F., de la Fuente-Núñez, C., Mansour, S., & Hancock, R. E. W. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03163-14 · Cited by 293
Liu, A., Tran, L., Becket, E., Lee, K., Chinn, L., Park, E., Tran, K., & Miller, J. H. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00906-09 · Cited by 286
Farha, M. A., Verschoor, C. P., Bowdish, D., & Brown, E. D. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.07.006 · Cited by 278
Agents that Inhibit Bacterial Biofilm Formation
Rabin, N., Zheng, Y., Opoku-Temeng, C., Du, Y., Bonsu, E., & Sintim, H. O. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.7 · Cited by 273
Brown, D. G., May-Dracka, T. L., Gagnon, M. M., & Tommasi, R. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501552x · Cited by 253
Antibiotic adjuvants: multicomponent anti-infective strategies
Kalan, L., & Wright, G. D. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001766 · Cited by 249
Self-citationClavulanic Acid, a Novel Inhibitor of β-Lactamases
Neu, H. C., & Fu, K. P. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.14.5.650 · Cited by 239
Inhibition of WTA Synthesis Blocks the Cooperative Action of PBPs and Sensitizes MRSA to β-Lactams
Farha, M. A., Leung, A., Sewell, E. W., D’Elia, M. A., Allison, S. E., Ejim, L., Pereira, P. M., Pinho, M. G., Wright, G. D., & Brown, E. D. (2013) · ACS Chemical Biology · doi:10.1021/cb300413m · Cited by 216
Self-citationAntibiotic combinations: should they be tested?
Eliopoulos, G. M., & Eliopoulos, C. T. (1988) · Clinical Microbiology Reviews · doi:10.1128/cmr.1.2.139 · Cited by 189
Bush, K. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.08.011 · Cited by 188
Zumla, A., Al-Tawfiq, J. A., Enne, V. I., Kidd, M., Drosten, C., Breuer, J., Muller, M. A., Hui, D., Maeurer, M., Bates, M., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70827-8 · Cited by 175
Brackman, G., Breyne, K., De Rycke, R., Vermote, A., Van Nieuwerburgh, F., Meyer, E., Van Calenbergh, S., & Coenye, T. (2016) · Scientific Reports · doi:10.1038/srep20321 · Cited by 174
New frontiers for anti-biofilm drug development
Ribeiro, S. M., Felício, M. R., Boas, E. V., Gonçalves, S., Costa, F. F., Samy, R. P., Santos, N. C., & Franco, O. L. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.02.006 · Cited by 142
Discovery of Wall Teichoic Acid Inhibitors as Potential Anti-MRSA β-Lactam Combination Agents
Wang, H., Gill, C., Lee, S. H., Mann, P. A., Zuck, P. D., Meredith, T. C., Murgolo, N., She, X., Kales, S., Liang, L., et al. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.11.013 · Cited by 136
New β‐lactam–β‐lactamase inhibitor combinations in clinical development
Shlaes, D. M. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12010 · Cited by 130
Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning
Wildenhain, J., Spitzer, M., Dolma, S., Jarvik, N., White, R., Roy, M. M., Griffiths, E., Bellows, D. S., Wright, G. D., & Tyers, M. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.003 · Cited by 127
Self-citationWright, G. D. (2015) · ACS Infectious Diseases · doi:10.1021/id500052s · Cited by 127
Self-citationA comprehensive regulatory framework to address the unmet need for new antibacterial treatments
Rex, J. H., Eisenstein, B. I., Alder, J. D., Goldberger, M. J., Meyer, R., Dane, A. L., Friedland, I. R., Knirsch, C. A., Sanhai, W. R., Tomayko, J. F., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70293-1 · Cited by 120
Antibiotic reimbursement in a model delinked from sales: a benchmark-based worldwide approach
Rex, J. H., & Outterson, K. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00500-9 · Cited by 113
Lee, S. H., Wang, H., Labroli, M. A., Koseoglu, S., Zuck, P. D., Mayhood, T., Gill, C., Mann, P. A., Sher, X., Ha, S., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad7364 · Cited by 110
Time for a change: addressing R&D and commercialization challenges for antibacterials
Payne, D. J., Miller, L. F., Findlay, D. M., Anderson, J., & Marks, L. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0086 · Cited by 102
Antibiotic adjuvants: identification and clinical use
Bernal, P., Molina‐Santiago, C., Daddaoua, A., & Llamas, M. A. (2013) · Microbial Biotechnology · doi:10.1111/1751-7915.12044 · Cited by 101
Broad-Spectrum Peptide Inhibitors of Aminoglycoside Antibiotic Resistance Enzymes
Boehr, D. D., Draker, K.-A., Koteva, K. K., Bains, M., Hancock, R. E. W., & Wright, G. D. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00026-7 · Cited by 90
Self-citationInsights into Newer Antimicrobial Agents against Gram-negative Bacteria
Yaneja, N., & Kaur, H. (2016) · Microbiology Insights · doi:10.4137/mbi.s29459 · Cited by 82
A Small Molecule Discrimination Map of the Antibiotic Resistance Kinome
Shakya, T., Stogios, P. J., Waglechner, N., Evdokimova, E., Ejim, L. J., Blanchard, J., McArthur, A. G., Savchenko, A. V., & Wright, G. D. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.10.018 · Cited by 78
Self-citationHarris, T., Worthington, R. J., & Melander, C. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201206911 · Cited by 78
A Forward Chemical Screen Identifies Antibiotic Adjuvants in Escherichia coli
Taylor, P. L., Rossi, L., Pascale, G. D., & Wright, G. D. (2012) · ACS Chemical Biology · doi:10.1021/cb300269g · Cited by 74
Self-citation7-Hydroxytropolone: an inhibitor of aminoglycoside-2"-O-adenylyltransferase
Allen, N. E., Alborn, W. E., Hobbs, J. N., & Kirst, H. A. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.5.824 · Cited by 70
Mann, P. A., Müller, A., Xiao, L., Pereira, P. M., Yang, C., Lee, S. H., Wang, H., Trzeciak, J., Schneeweis, J. E., dos Santos, M. M., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400487f · Cited by 69
A robust platform for chemical genomics in bacterial systems
French, S., Mangat, C. S., Bharat, A., Côté, J., Mori, H., & Brown, E. D. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-08-0573 · Cited by 69
Stogios, P. J., Spanogiannopoulos, P., Evdokimova, E., Egorova, O., Shakya, T., Todorovic, N., Capretta, A. A., Wright, G. D., & Savchenko, A. V. (2013) · Biochemical Journal · doi:10.1042/bj20130317 · Cited by 60
Self-citationSuppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 2
Drusano, G. L., Hope, W. W., MacGowan, A. P., & Louie, A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02231-15 · Cited by 55
Palmitoyl‐ dl ‐Carnitine is a Multitarget Inhibitor of Pseudomonas aeruginosa Biofilm Development
Wenderska, I. B., Chong, M., McNulty, J., Wright, G. D., & Burrows, L. L. (2011) · ChemBioChem · doi:10.1002/cbic.201100500 · Cited by 53
Self-citationCox, G., Koteva, K. K., & Wright, G. D. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku057 · Cited by 51
Self-citationHirsch, D. R., Cox, G., D’Erasmo, M. P., Shakya, T., Meck, C., Mohd, N., Wright, G. D., & Murelli, R. P. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.09.037 · Cited by 50
Self-citationSmall Molecule Suppression of Carbapenem Resistance in NDM-1 Producing Klebsiella pneumoniae
Worthington, R. J., Bunders, C. A., Reed, C. S., & Melander, C. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200290p · Cited by 50
Small-Molecule Modulators of Listeria monocytogenes Biofilm Development
Nguyen, U., Wenderska, I. B., Chong, M., Koteva, K. K., Wright, G. D., & Burrows, L. L. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.07227-11 · Cited by 48
Self-citationA macrophage-stimulating compound from a screen of microbial natural products
Perry, J. A., Koteva, K. K., Verschoor, C. P., Wang, W., Bowdish, D. M. E., & Wright, G. D. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2014.83 · Cited by 42
Self-citation
Cited by
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Drug combinations: a strategy to extend the life of antibiotics in the 21st century
Tyers, M., & Wright, G. D. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0141-x · Cited by 820
Self-citationThe past, present, and future of antibiotics
Cook, M. A., & Wright, G. D. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo7793 · Cited by 652
Self-citationNext-generation approaches to understand and combat the antibiotic resistome
Crofts, T. S., Gasparrini, A. J., & Dantas, G. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.28 · Cited by 535
A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens
Song, M., Liu, Y., Huang, X., Ding, S., Wang, Y., Shen, J., & Zhu, K. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0723-z · Cited by 484
Metadata
- Authors
- Wright, G. D.
- Venue
- Trends in Microbiology
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 24
- Issue
- 11
- Pages
- 862-871
- ISSN
- 0966-842X (ISSN-L)
- OpenAlex
- W2489596030
- Cited by
- 604
- References
- 54
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.